Advice, information, and resources to help women navigate every stage of life, supporting both physical and mental wellbeing.
Women on TikTok are claiming that an unlikely combination of allergy and heartburn medicines can reduce severe premenstrual symptoms. Videos describe improvements in irritability, anxiety, low mood, insomnia, brain fog and even hot flushes after taking an H1 antihistamine, such as fexofenadine, alongside famotidine, an H2 blocker normally used for heartburn.
Some users say the combination has transformed their experience of premenstrual dysphoric disorder (PMDD), a severe cyclical condition that can cause depression, anxiety, anger and other debilitating symptoms in the weeks before a period.
The medicines are inexpensive and widely available without a prescription, which has helped the claim spread rapidly. But does the apparent “antihistamine hack” have any proper scientific evidence behind it?
The theory circulating online is that hormonal changes around the menstrual cycle can affect histamine, a chemical involved in allergic reactions and several other processes in the body. Some influencers claim that rising and falling oestrogen levels cause excess histamine activity, which then contributes to PMS or PMDD symptoms.
The suggested solution is usually an H1 antihistamine, which blocks the receptor associated with familiar allergy symptoms, combined with famotidine, which blocks H2 receptors and reduces stomach acid. Famotidine is better known as a heartburn medicine than an allergy tablet, although it also acts on part of the body’s histamine system.
There is enough biology behind the theory to make it sound convincing. Oestrogen can interact with mast cells, which release histamine, and some people find their allergic symptoms change during their menstrual cycle. However, a plausible theory is not the same as proof that histamine causes PMS or PMDD—or that blocking it will provide a safe and effective treatment.
The short answer is that there is currently no good clinical evidence showing that antihistamines or famotidine treat PMS or PMDD.
Allergist and clinical immunologist Dr Zachary Rubin has said that, while patients report dramatic improvements and there are possible reasons why the medicines might help, there are no clinical trials validating the treatment. Other women report no benefit at all.
Dr Alison Huang, director of the Women’s Health Clinical Research Center at the University of California, San Francisco, has also cautioned that current expert opinion does not consider premenstrual or perimenopausal symptoms to be primarily driven by histamine. Any improvement could be indirect; for example, a sedating antihistamine might improve sleep, which could make mood and fatigue feel better the following day.
The International Association for Premenstrual Disorders reportedly concluded in a May 2026 position statement that there was insufficient evidence to identify histamine intolerance, mast-cell activation or related immune mechanisms as a primary cause of premenstrual disorders. Researchers have not established which women, if any, are most likely to benefit, which medicines should be used, what dose would be appropriate or what the longer-term risks might be.
This does not mean that every woman describing an improvement is mistaken. Individual experiences can help generate valuable research questions. They cannot, however, establish whether the medicine caused the improvement, whether the effect will continue or whether an underlying condition has been missed.
Antihistamines are widely used, but that does not make them risk-free or suitable for everyone. Depending on the medicine, side effects can include drowsiness, dizziness, dry mouth, headache and difficulty concentrating. Sedating antihistamines may affect driving, work and the ability to care safely for children.
Famotidine is generally used to reduce stomach acid. Regular or prolonged use may not be appropriate for everyone and could affect the absorption of some nutrients or interact with other medicines. Women who are pregnant, breastfeeding, living with another medical condition or taking prescription medication should speak to a pharmacist or doctor before experimenting with the combination.
There is also a risk that self-treatment delays proper assessment. Severe cyclical symptoms could indicate PMDD, while pain, heavy bleeding, fatigue or mood changes may have other causes requiring different treatment.
Women who suspect PMS or PMDD should consider recording their symptoms across at least two menstrual cycles. The timing matters: PMDD symptoms typically appear during the luteal phase before a period and improve shortly after menstruation begins. A symptom diary can help a GP establish whether there is a consistent cyclical pattern.
Evidence-based options for severe premenstrual symptoms can include selective serotonin reuptake inhibitors, hormonal treatments, cognitive behavioural therapy and lifestyle support, depending on the woman’s symptoms, medical history and preferences. PMDD is a genuine and potentially serious condition, particularly where symptoms include severe depression, hopelessness or suicidal thoughts.
The TikTok claim is therefore not entirely biologically implausible, but it has raced far ahead of the evidence. Antihistamines may eventually prove helpful for a particular group of women, but medicine has not yet established who that group might be, or whether the apparent benefits outweigh the risks.
For now, the answer is clear: women’s experiences deserve further research, but an untested social-media treatment should not replace an individual medical assessment.
Medical disclaimer: This article is for general information only and is not a substitute for individual medical advice, diagnosis or treatment. If you are concerned about your symptoms, contact your GP, pharmacist or another qualified healthcare professional. Seek urgent medical help if symptoms are severe, worsening or you believe you may be experiencing an emergency.
Wellbeing looks different for everyone, and sometimes the most useful thing is simply finding the right information at the right time. Explore more from Daily Round with our dedicated Women’s Health, Men’s Wellbeing and Wellbeing for Leaders sections, or head to the Leaders Library for our latest book recommendations, ideas and inspiration for life in and outside work.
Posted by:
Mehala
Editorial Assistant – The Daily Round
Busy day? We’ve got you covered. Get FREE daily news, practical insights, opportunities and wellbeing content, carefully curated for busy health and social care professionals. Just enter your details below to get The Daily Briefing delivered straight to your inbox.